Lung Cancer 2018: Progress and Future Directions

Lung Cancer 2018: Progress and Future Directions Banner


Date & Location
Saturday, December 8, 2018, 7:00 AM - 4:00 PM, The Wink Hotel, Washington, DC, Washington, DC

Target Audience
Medical Oncology, Oncology, Radiation Oncology, Radiology, Surgery

Overview

This one-day symposium will provide a comprehensive update on recent advances in the care of patients with thoracic malignancies. There is increasing recognition of a gap between evidence-based guidelines and clinical practice, with research demonstrating that up to 40% of patients fail to receive effective therapies and 20% of patients receive therapies that are ineffective or even harmful.  Reducing these gaps leads to reduction in patient morbidity and mortality, and decreased health care costs. With the rapid advances in thoracic oncology, this symposium attempts to crystallize current knowledge and provide critical information and key take-home points to the busy practicing clinician involved in the care of patients with thoracic malignancies. Key focus topics will include guidelines to establish an effective clinically oriented smoking cessation program, the changes to lung cancer staging using the IASLC 8th edition guidelines, novel diagnostic tools such as robotic bronchoscopy, patient selection for multi-modality therapy in locally advanced lung cancer including surgical controversies and role of immunotherapy and proton beam radiation, advances in the biology and management of small cell lung cancer, and recent advances in immuno-oncology and targeted therapies in lung cancer. The symposium will also focus on strategies to detect and manage toxicities of immunotherapy for nurses and pharmacists. This symposium will review all of the recent advances in a highly interactive case-based discussion format, supported by didactic lectures by thought leaders and other well-respected faculty in each field.



Objectives

Physicians

  1. Determine strategies to establish an effective evidence-based clinical smoking cessation program.
  2. Apply the 8th edition of the IASLC staging system and utilize appropriate staging modalities to arrive at the correct stage to guide evidence-based treatment options.
  3. Critique the use of novel diagnostic tools such as robotic bronchoscopy.
  4. Debate the controversies surrounding clinical decision making in locally advanced lung cancer including the role of surgery, proton beam radiation and immunotherapy.
  5. Explain the evolving data pertaining to immuno-oncology in lung cancer with emphasis on appropriate sequencing/combination with chemotherapy and the role of potential biomarkers for immunotherapy.
  6. Discuss recent progress and future directions in the development of targeted therapies for lung cancer, in common and uncommon oncogenic mutation driven lung cancer.
  7. Evaluate the latest advances in the biology and management of small cell lung cancer.

Nurses 

  1. Discuss nursing strategies for early detection of immune-mediated toxicities.
  2. Recognize common immune related adverse effects and factors that increase patient's risk of developing immune-related adverse effects.

Pharmacists

  1. Evaluate the pharmacologic management of immune-related adverse events based on current guidelines and evidence
  2. Recognize common immune related adverse effects and factors that increase patient's risk of developing immune-related adverse effects
  3. Recommend monitoring and supportive care measures for medications initiated to manage immune-related adverse effects

Registration


Registration Fees:

Now – December 6

On-Site

Physician

$175

$200

Resident or Fellow

$75

$75

Physician Assistant

$100

$125

Nurse Practitioner

$100

$125

Nurse

$100

$125

Pharmacist

$100

$125

Allied Health Professional

$100

$125

Industry Professional

$250

$300



Accreditation

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC)and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.



Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 6.25 Interprofessional Continuing Education (IPCE) credits for learning and change.




This conference has been endorsed by: